{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:28:46Z","timestamp":1761845326289,"version":"3.37.3"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Allergy Asthma Clin Immunol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Erdheim-Chester disease (ECD) is a rare non-Langerhans histiocytosis with slow progression over the years that is particularly difficult to diagnose.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Cases<\/jats:title>\n                <jats:p>Here we report three cases of ECD without <jats:italic>BRAF<\/jats:italic> mutation presenting with a renal mass, hairy kidney appearance, and a rather benign course, for which the diagnosis of ECD was delayed, characterized by multiple investigations and unsuccessful treatments attempts. In two cases the distinction from IgG4-related disease required multiple investigations and reevaluation of the clinical, radiological, histological, and immunological characteristics.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>A correct diagnosis of ECD may take several years and often requires revisiting previous hypotheses. Reassessment of histological slides and more modern complementary exams such as PET-CT or <jats:italic>BRAF<\/jats:italic> and <jats:italic>MAPK-ERK<\/jats:italic> mutation analysis can help to confirm the diagnosis of ECD and to select effective therapy.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13223-020-00505-2","type":"journal-article","created":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T20:05:26Z","timestamp":1609963526000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Three cases of BRAF mutation negative Erdheim-Chester disease with a challenging distinction from IgG4-related disease"],"prefix":"10.1186","volume":"17","author":[{"given":"David","family":"Spoerl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8352-988X","authenticated-orcid":false,"given":"Rapha\u00ebl","family":"Andr\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aur\u00e9lie","family":"Bornand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rg D.","family":"Seebach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,6]]},"reference":[{"key":"505_CR1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019003507","author":"G Goyal","year":"2020","unstructured":"Goyal G, Heaney M, Collin M, Cohen Aubart F, Vaglio A, Durham BH, et al. Erdheim-Chester disease: consensus recommendations for the evaluation, diagnosis, and treatment in the molecular era. Blood. 2020. https:\/\/doi.org\/10.1182\/blood.2019003507.","journal-title":"Blood"},{"key":"505_CR2","first-page":"53","volume":"24","author":"J Haroche","year":"2012","unstructured":"Haroche J, Arnaud L, Amoura Z. Erdheim-Chester disease. CurrOpinRheumatol. 2012;24:53\u20139.","journal-title":"CurrOpinRheumatol"},{"key":"505_CR3","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1182\/blood-2010-06-294108","volume":"117","author":"L Arnaud","year":"2011","unstructured":"Arnaud L, Hervier B, Neel A, Hamidou MA, Kahn JE, Wechsleret B, et al. CNS involvement and treatment with interferon-alpha are independent prognostic factors in Erdheim-Chester disease: a multicenter survival analysis of 53 patients. Blood. 2011;117:2778\u201382.","journal-title":"Blood"},{"key":"505_CR4","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1097\/00005792-199605000-00005","volume":"75","author":"C Veyssier-Belot","year":"1996","unstructured":"Veyssier-Belot C, Cacoub P, Caparros-Lefebvre D, Wechsler J, Brun B, Remy M, et al. Erdheim-Chester disease. Clinical and radiologic characteristics of 59 cases. Medicine. 1996;75:157\u201369.","journal-title":"Medicine."},{"key":"505_CR5","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1097\/01.md.0000145368.17934.91","volume":"83","author":"J Haroche","year":"2004","unstructured":"Haroche J, Amoura Z, Dion E, Wechsler B, Costedoat-Chalumeau N, Cacoubet P, et al. Cardiovascular involvement, an overlooked feature of Erdheim-Chester disease: report of 6 new cases and a literature review. Medicine. 2004;83:371\u201392.","journal-title":"Medicine"},{"key":"505_CR6","doi-asserted-by":"publisher","first-page":"e3625","DOI":"10.1097\/MD.0000000000003625","volume":"95","author":"D Gianfreda","year":"2016","unstructured":"Gianfreda D, Musetti C, Nicastro M, Maritati F, Cobelli R, Corradi D, et al. Erdheim-Chester disease as a mimic of IgG4-related disease: a case report and a review of a single-center cohort. Medicine (Baltimore). 2016;95:e3625.","journal-title":"Medicine (Baltimore)"},{"key":"505_CR7","doi-asserted-by":"publisher","first-page":"e502","DOI":"10.3324\/haematol.2018.214007","volume":"104","author":"A Roeser","year":"2019","unstructured":"Roeser A, Cohen-Aubart F, Breillat P, Miyara M, Emile JF, Charlotte F, et al. Autoimmunity associated with Erdheim-Chester disease improves with BRAF\/MEK inhibitors. Haematologica. 2019;104:e502\u20135.","journal-title":"Haematologica"},{"key":"505_CR8","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.jaci.2014.03.034","volume":"134","author":"H Mattoo","year":"2014","unstructured":"Mattoo H, Mahajan VS, Della-Torre E, Sekigami Y, Carruthers M, Wallace ZS, et al. De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG4-related disease. J Allergy ClinImmunol. 2014;134:679\u201387.","journal-title":"J Allergy ClinImmunol"},{"issue":"8","key":"505_CR9","doi-asserted-by":"publisher","first-page":"e85","DOI":"10.1093\/ibd\/izaa129","volume":"26","author":"J Razanamahery","year":"2020","unstructured":"Razanamahery J, Humbert S, Weil-Verhoeven D, Emile J-F, Vuitton L, Magy-Bertrand N. Refractory inflammatory bowel disease associated with sclerosing cholangitis, diabetes insipidus, and myeloid neoplasm: langerhans cell histiocytosis was hiding since the beginning. Inflamm Bowel Dis. 2020;26(8):e85\u20136.","journal-title":"Inflamm Bowel Dis"}],"container-title":["Allergy, Asthma &amp; Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13223-020-00505-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13223-020-00505-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13223-020-00505-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T22:06:35Z","timestamp":1609970795000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacijournal.biomedcentral.com\/articles\/10.1186\/s13223-020-00505-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,6]]},"references-count":9,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["505"],"URL":"https:\/\/doi.org\/10.1186\/s13223-020-00505-2","relation":{},"ISSN":["1710-1492"],"issn-type":[{"type":"electronic","value":"1710-1492"}],"subject":[],"published":{"date-parts":[[2021,1,6]]},"assertion":[{"value":"29 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All patients or families have given their consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declared that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6"}}